PLANET LABS PBC (PL)

US72703X1063 - Common Stock

1.78  -0.7 (-28.23%)

After market: 1.82 +0.04 (+2.25%)

Fundamental Rating

4

PL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 80 industry peers in the Professional Services industry. No worries on liquidiy or solvency for PL as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PL is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

PL had negative earnings in the past year.
In the past year PL has reported a negative cash flow from operations.
PL had negative earnings in each of the past 5 years.
In the past 5 years PL always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -20.07%, PL is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -27.06%, PL is doing worse than 78.75% of the companies in the same industry.
Industry RankSector Rank
ROA -20.07%
ROE -27.06%
ROIC N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 51.36%, PL is in the better half of the industry, outperforming 61.25% of the companies in the same industry.
In the last couple of years the Gross Margin of PL has grown nicely.
The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PL has more shares outstanding
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.18, we must say that PL is in the distress zone and has some risk of bankruptcy.
PL's Altman-Z score of 0.18 is on the low side compared to the rest of the industry. PL is outperformed by 77.50% of its industry peers.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.18
ROIC/WACCN/A
WACC8.36%

2.3 Liquidity

PL has a Current Ratio of 2.74. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.74, PL belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
A Quick Ratio of 2.74 indicates that PL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.74, PL belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.74

6

3. Growth

3.1 Past

PL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.10%, which is quite impressive.
Looking at the last year, PL shows a quite strong growth in Revenue. The Revenue has grown by 15.37% in the last year.
The Revenue has been growing by 24.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)55.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)15.37%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

Based on estimates for the next years, PL will show a very strong growth in Earnings Per Share. The EPS will grow by 26.69% on average per year.
The Revenue is expected to grow by 19.18% on average over the next years. This is quite good.
EPS Next Y28.33%
EPS Next 2Y25.94%
EPS Next 3Y26.69%
EPS Next 5YN/A
Revenue Next Year15.75%
Revenue Next 2Y16.75%
Revenue Next 3Y19.18%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 26.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.94%
EPS Next 3Y26.69%

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (9/6/2024, 8:04:01 PM)

After market: 1.82 +0.04 (+2.25%)

1.78

-0.7 (-28.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap517.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.07%
ROE -27.06%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.74
Quick Ratio 2.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)55.1%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y28.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.37%
Revenue growth 3Y24.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y